These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 3014941

  • 1. Treatment of cytomegalovirus pneumonia with 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine and high-dose corticosteroids.
    Reed EC, Dandliker PS, Meyers JD.
    Ann Intern Med; 1986 Aug; 105(2):214-5. PubMed ID: 3014941
    [No Abstract] [Full Text] [Related]

  • 2. Treatment of cytomegalovirus pneumonitis after bone marrow transplantation with 9-[2-hydroxy-1-(hydroxymethyl) ethoxymethyl] guanine.
    Selby P, Powles RL, Jameson B, Stolle K, Tryhorn Y, Stern H.
    Lancet; 1986 Jun 14; 1(8494):1377-8. PubMed ID: 2872484
    [No Abstract] [Full Text] [Related]

  • 3. Activity of 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine in the treatment of cytomegalovirus pneumonia.
    Shepp DH, Dandliker PS, de Miranda P, Burnette TC, Cederberg DM, Kirk LE, Meyers JD.
    Ann Intern Med; 1985 Sep 14; 103(3):368-73. PubMed ID: 2992333
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Ganciclovir and hyperimmunoglobulin for treating cytomegalovirus infection in bone marrow transplant recipients.
    Aulitzky WE, Tilg H, Niederwieser D, Hackl M, Meister B, Huber C.
    J Infect Dis; 1988 Aug 14; 158(2):488-9. PubMed ID: 2841384
    [No Abstract] [Full Text] [Related]

  • 6. Tolerance and efficacy of ganciclovir in the treatment of cytomegalovirus infections in immunosuppressed patients.
    Ho WG, Winston DJ, Champlin RE.
    Transplant Proc; 1989 Feb 14; 21(1 Pt 3):3103-6. PubMed ID: 2539690
    [No Abstract] [Full Text] [Related]

  • 7. Ganciclovir treatment of cytomegalovirus disease in transplant recipients and other immunocompromised hosts.
    Erice A, Jordan MC, Chace BA, Fletcher C, Chinnock BJ, Balfour HH.
    JAMA; 1987 Jun 12; 257(22):3082-7. PubMed ID: 3035246
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Massive cytomegalovirus pneumonia and myocarditis in a renal transplant recipient: successful treatment with DHPG.
    Shabtai M, Luft B, Waltzer WC, Anaise D, Rapaport FT.
    Transplant Proc; 1988 Jun 12; 20(3):562-3. PubMed ID: 2837853
    [No Abstract] [Full Text] [Related]

  • 10. Ganciclovir therapy for cytomegalovirus infections in recipients of bone marrow transplants and other immunosuppressed patients.
    Winston DJ, Ho WG, Bartoni K, Holland GN, Mitsuyasu RT, Gale RP, Busuttil RW, Champlin RE.
    Rev Infect Dis; 1988 Jun 12; 10 Suppl 3():S547-53. PubMed ID: 2847292
    [Abstract] [Full Text] [Related]

  • 11. Treatment of cytomegalovirus pneumonitis with ganciclovir in renal transplantation.
    Stoffel M, Pirson Y, Squifflet JP, Lamy M, Gianello P, Alexandre GP.
    Transpl Int; 1988 Dec 12; 1(4):181-5. PubMed ID: 2855305
    [Abstract] [Full Text] [Related]

  • 12. Ganciclovir therapy for cytomegalovirus disease associated with renal transplants.
    Snydman DR.
    Rev Infect Dis; 1988 Dec 12; 10 Suppl 3():S554-62. PubMed ID: 2847293
    [Abstract] [Full Text] [Related]

  • 13. Ganciclovir for treatment of renal transplant-associated primary cytomegalovirus pneumonia.
    Hecht DW, Snydman DR, Crumpacker CS, Werner BG, Heinze-Lacey B.
    J Infect Dis; 1988 Jan 12; 157(1):187-90. PubMed ID: 2826608
    [No Abstract] [Full Text] [Related]

  • 14. DHPG (Gancyclovir) improves survival in CMV pneumonia.
    Mai M, Nery J, Sutker W, Husberg B, Klintmalm G, Gonwa T.
    Transplant Proc; 1989 Feb 12; 21(1 Pt 2):2263-5. PubMed ID: 2540565
    [No Abstract] [Full Text] [Related]

  • 15. Treatment of cytomegalovirus pneumonia with high-dose acyclovir.
    Wade JC, Hintz M, McGuffin R, Springmeyer SC, Connor JD, Meyers JD.
    Am J Med; 1982 Jul 20; 73(1A):249-56. PubMed ID: 6285716
    [Abstract] [Full Text] [Related]

  • 16. Ganciclovir treatment of serious cytomegalovirus infection in heart and heart-lung transplant recipients.
    Keay S, Petersen E, Icenogle T, Zeluff BJ, Samo T, Busch D, Newman CL, Buhles WC, Merigan TC.
    Rev Infect Dis; 1988 Jul 20; 10 Suppl 3():S563-72. PubMed ID: 2847294
    [Abstract] [Full Text] [Related]

  • 17. Treatment of cytomegalovirus pneumonia.
    Crumpacker C, Marlowe S, Zhang JL, Abrams S, Watkins P.
    Rev Infect Dis; 1988 Jul 20; 10 Suppl 3():S538-46. PubMed ID: 2847291
    [Abstract] [Full Text] [Related]

  • 18. Ganciclovir treatment of cytomegalovirus infections in iatrogenically immunocompromised patients.
    Keay S, Bissett J, Merigan TC.
    J Infect Dis; 1987 Dec 20; 156(6):1016-21. PubMed ID: 2824621
    [No Abstract] [Full Text] [Related]

  • 19. Ganciclovir therapy in iatrogenically immunosuppressed patients with cytomegalovirus disease.
    Thomson MH, Jeffries DJ.
    J Antimicrob Chemother; 1989 Jun 20; 23 Suppl E():61-70. PubMed ID: 2550413
    [Abstract] [Full Text] [Related]

  • 20. Effect of 9-(1,3-dihydroxy-2-propoxymethyl) guanine on serious cytomegalovirus disease in eight immunosuppressed homosexual men.
    Masur H, Lane HC, Palestine A, Smith PD, Manischewitz J, Stevens G, Fujikawa L, Macher AM, Nussenblatt R, Baird B.
    Ann Intern Med; 1986 Jan 20; 104(1):41-4. PubMed ID: 3000248
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.